Stay updated with breaking news from William Hoffman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Morgan Stanley restated their overweight rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. The brokerage currently has a $83.00 target price on the stock. Several other equities research analysts have also recently commented on the stock. Robert W. Baird assumed coverage […]
Texas Permanent School Fund Corp increased its stake in shares of Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 33.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 43,305 shares of the company’s stock after acquiring an additional 10,842 shares during the quarter. Texas […]
Inari Medical (NASDAQ:NARI – Free Report) had its price target trimmed by Truist Financial from $70.00 to $65.00 in a report issued on Wednesday morning, Marketbeat reports. The brokerage currently has a hold rating on the stock. Separately, Robert W. Baird started coverage on shares of Inari Medical in a research note on Tuesday, July […]
Robert W. Baird initiated coverage on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $79.00 price target on the stock. Separately, Truist Financial raised their target price on shares of Inari Medical from $68.00 to $70.00 […]
Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) Director William Hoffman sold 25,000 shares of Inari Medical stock in a transaction on Monday, July 17th. The shares were sold at an average price of $57.08, for a total value of $1,427,000.00. Following the sale, the director now directly owns 1,073,055 shares of the company’s stock, […]